Specificity, degeneracy, and molecular mimicry in antigen recognition by HLA-Class II restricted T cell receptors: implications for clinical medicine

References

• Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO, et al. A molecular basis for MHC class II-associated autoimmunity. Science 1988;240:1003–9.
   PubMed Web of Science ®Google Scholar
• Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature 1999;402:255–62.
   PubMedGoogle Scholar
• Horwitz MS, Sarvetnick N. Viruses, host responses, and autoim-munity. Immunol Rev 1999;169:241–53.
   PubMed Web of Science ®Google Scholar
• Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863–9.
   PubMed Web of Science ®Google Scholar
• Mellman I, Steinman RM. Dendritic cells: specialized and regu-lated antigen processing machines. Cell 2001;106:255–8.
   PubMed Web of Science ®Google Scholar
• Rescigno M, Borrow P. The host-pathogen interaction: new themes from dendritic cell biology. Cell 2001;106:267–70.
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001;106:263–6.
   PubMed Web of Science ®Google Scholar
• Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001;106:259–62.
   PubMed Web of Science ®Google Scholar
• Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155–7.
   PubMed Web of Science ®Google Scholar
• Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997;3: 1133–6.
   PubMed Web of Science ®Google Scholar
• Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998;4:781–5.
   PubMed Web of Science ®Google Scholar
• Scherer MT, Ignatowicz L, Winslow GM, Kappler JW, Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 1993;9:101–28.
   Google Scholar
• Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman CG, et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 1993;365:642–4.
   PubMed Web of Science ®Google Scholar
• Dalwadi H, Wei B, Kronenberg M, Sutton CL, Braun J. The Crohn's disease-associated bacterial protein 12 is a novel enteric T cell superantigen. Immunity 2001;15: 149–58.
   Google Scholar
• Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J 1998;12:1255–65.
   PubMed Web of Science ®Google Scholar
• Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985;230:1043–5.
   PubMed Web of Science ®Google Scholar
• Hausmann S, Martin M, Gauthier L, Wucherpfennig KW. Struc-tural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition. J Immunol 1999;162:338–44.
   PubMed Web of Science ®Google Scholar
• Hiemstra HS, Schloot NC, van Veelen PA, Willemen SJ, Franken KL, van Rood JJ, et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001;98:3988–91.
   Google Scholar
• Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998;281: 703–6.
   Google Scholar
• Sigal LH. Immunologic mechanisms in Lyme neuroborreliosis: the potential role of autoimmunity and molecular mimicry. Semin Neurol 1997;17:63–8.
   PubMed Web of Science ®Google Scholar
• Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998;279: 1344–7.
   Google Scholar
• Panoutsakopoulou V, Sanchirico ME, Huster KM, Jansson M, Granucci F, Shim DJ, et al. Analysis of the relationship between viral infection and autoimmune disease. Immunity 2001;15:137–47.
   PubMed Web of Science ®Google Scholar
• Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger 46. JM. Chlamydia infections and heart disease linked through anti-genic mimicry. Science 1999;283:1335–9.
   Google Scholar
• Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD. 47. A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest 2001;108: 311–8.
   Google Scholar
• Oldstone MB. Molecular mimicry and autoimmune disease. Cell 1987;50:819–20.
   PubMed Web of Science ®Google Scholar
• Mason D. A very high level of crossreactivity is an essential featureaof the T-cell receptor. Immunol Today 1998;19:395-404.48.
   Google Scholar
• Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cellclones specific for myelin basic protein. Cell 1995;80:695-705.49.
   Google Scholar
• Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, et al. Identification of high-potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. 50. J Exp Med 1997;185:1651–9.
   PubMed Web of Science ®Google Scholar
• Chen YZ, Matsushita S, Nishimura Y. Response of a human T cell clone to a large panel of altered peptide ligands carrying single 51. residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation. J Immunol 1996;157: 3783–90.
   Google Scholar
• Maier B, Molinger M, Cope AP, Fugger L, Schneider-Mergener 52. J, Sonderstrup G, et al. Multiple cross-reactive self-ligands for Borrelia burgdorferi-specific HLA-DR4-restricted T cells. Eur J Immunol 2000;30: 448–57.
   PubMed Web of Science ®Google Scholar
• Kanai T, Nomura Y, Segawa M, Takagi K, Senju S, Matsushita S, 53. et al. Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor alpha subunit pep-tide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis. Hum Immunol 1997;56: 28–38.54.
   Google Scholar
• Rammensee HG, Friede T, Stevanoviic S. MHC ligands and pep-tide motifs: first listing. Immunogenetics 1995;41:178–228.
   Google Scholar
• Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, et al. Promiscuous and allele-specific anchors in HLA-DR-bindingpeptides. Cell 1993;74:197-203.55.
   Google Scholar
• Ghosh P, Amaya M, Mellins E, Wiley DC. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-aDR3. Nature 1995;378:457-62.56.
   PubMedGoogle Scholar
• Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215–21.
   PubMed Web of Science ®Google Scholar
• Arden B, Clark SP, Kabelitz D, Mak TW. Human T-cell receptor 57. variable gene segment families. Immunogenetics 1995;42:455–500.
   PubMedGoogle Scholar
• Hennecke J, Wiley DC. T cell receptor-MHC interactions up close. Cell 2001;104:1–4.
   PubMed Web of Science ®Google Scholar
• Ding YH, Baker BM, Garboczi DN, Biddison WE, Wiley DC. 58. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 1999;11: 45–56.
   Google Scholar
• Reinherz EL, Tan K, Tang L, Kern P, Liu J, Xiong Y, et al. The 59. crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 1999;286:1913–21.
   Google Scholar
• Hennecke J, Carfi A, Wiley DC. Structure of a covalently stabi-lized complex of a human alphabeta T-cell receptor, influenza 60. HA peptide and MHC class II molecule, HLA-DR1. EMB 0 J 2000;19: 5611–24.
   Google Scholar
• Esnouf RM. An extensively modified version of MolScript that includes greatly enhanced colouring capabilities. J Mol Graph 61. Model 1997;15:132–4.
   Google Scholar
• De Magistris MT, Alexander J, Coggeshall M, Altman A, Gaeta FC, Grey HM, et al. Antigen analog-major histocompatibility com- 62. plexes act as antagonists of the T cell receptor. Cell 1992;68:625–34.
   Google Scholar
• Racioppi L, Ronchese F, Matis LA, Germain RN. Peptide-major histocompatibility complex class II complexes with mixed agonist/ antagonist properties provide evidence for ligand-related differ- 63. ences in T cell receptor-dependent intracellular signaling. J Exp Med 1993;177:1047–60.
   Google Scholar
• Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presentingcells. Nature 1993;363: 156–9.64.
   Google Scholar
• Sloan-Lancaster J, Evavold BD, Allen PM. Th2 cell clonal anergy as a consequence of partial activation. J Exp Med 1994;180: 1195–205.
   Google Scholar
• Evavold BD, Allen PM. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science1991;252:1308–10.
   PubMed Web of Science ®Google Scholar
• Soloway P, Fish S, Passmore H, Gefter M, Coffee R, Manser T. Regulation of the immune response to peptide antigens: differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype. J Exp Med 1991;174:847–a58.
   Web of Science ®Google Scholar
• Kersh GJ, Kersh EN, Fremont DH, Allen PM. High- and lowpotency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 1998;9:817–26.
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Omori Y, Nieda M, Kuwata S, Tokunaga K, Juji T. HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome. Lancet 1992;340.
   PubMed Web of Science ®Google Scholar
• Chen YZ, Matsushita S, Nishimura Y. A single residue polymorphism at DR beta 37 affects recognition of peptides by T cells. Hum Immunol 1997;54: 30–9.
   Google Scholar
• Kersh GJ, Allen PM. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J Exp Med1996;184:1259–68.
   PubMed Web of Science ®Google Scholar
• Kersh GJ, Miley MJ, Nelson CA, Grakoui A, Horvath S, Donermeyer DL, et al. Structural and functional consequences of altering a peptide MHC anchor residue. J Immunol 2001;166:3345–54.
   PubMed Web of Science ®Google Scholar
• Hiemstra HS, van Veelen PA, Schloot NC, Geluk A, van Meijgaarden KE, Willemen SJ, et al. Definition of natural T cell antigens with mimicry epitopes obtained from dedicated synthetic peptide libraries. J Immunol 1998;161:4078–82.
   PubMed Web of Science ®Google Scholar
• Grogan JL, Kramer A, Nogai A, Dong L, Ohde M, Schneider- Mergener J, et al. Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice. J Immunol1999;163:3764–70.
   Google Scholar
• Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A, et al. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med 1999;5:1375–82.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Gran B, Pinilla C, Markovic-Plese S, Hemmer B, Tzou A, et al. Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J Immunol 2001;167:2130–41.
   Google Scholar
• Tanaka Y, Ohyama H, Ogawa M, Nishimura Y, Matsushita S. Identification of peptide superagonists for a self-K-ras-reactive CD4 T cell clone using combinatorial peptide libraries and mass spectrometry. J Immunol 1999;162: 7155–61.
   Google Scholar
• Leggatt GR, Hosmalin A, Pendleton CD, Kumar A, Hoffman S, Berzofsky JA. The importance of pairwise interactions between peptide residues in the delineation of TCR specificity. J Immunol1998;161:4728.
   PubMed Web of Science ®Google Scholar
• Ausubel LJ, Kwan CK, Sette A, Kuchroo V, Hafler DA. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones. Proc Natl Acad Sci USA1996;93:15317–22.
   Google Scholar
• Uemura Y, Senju S, Maenaka K, Iwai LK, Fujii S, Tabata H, et al. Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for GAD65-specific TCRs. J Immunol 2003;170:947–60.
   PubMed Web of Science ®Google Scholar
• Fujii S, Uemura Y, Iwai LK, Ando M, Senju S, Nishimura Y. Establishment of an expression cloning system for CD4 T cell epitopes. Biochem Biophys Res Commun 2001;284:1140–7.
   PubMed Web of Science ®Google Scholar
• van Bergen J, Schoenberger SP, Verreck F, Amons R, Offringa R, Koning F. Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP. Proc Natl Acad Sci USA 1997;94:7499–502.
   PubMed Web of Science ®Google Scholar
• Malcherek G, Wirblich C, Willcox N, Rammensee HG, Trowsdale J, Melms A. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation. Eur J Immunol 1998;28:1524–33.
   PubMed Web of Science ®Google Scholar
• Fujii S, Senju S, Chen YZ, Ando M, Matsushita S, Nishimura Y. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells. Hum Immunol1998;59:607–14.
   PubMed Web of Science ®Google Scholar
• Senju S, Hirata S, Matsuyosi H, Masuda M, Uemura Y, Araki K, et al. Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells. Blood 2003;101:3501–8.
   PubMed Web of Science ®Google Scholar
• Tabata H, Kanai T, Yoshizumi H, Nishiyama S, Fujimoto S, Matsuda I, et al. Characterization of self-glutamic acid decarboxy-lase 65-reactive CD4+ T-cell clones established from Japanese pa-tients with insulin-dependent diabetes mellitus. Hum Immunol 1998;59:549–60.
   PubMed Web of Science ®Google Scholar
• Anderton SM, Manickasingham SP, Burkhart C, Luckcuck TA, Holland SJ, Lamont AG, et al. Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity. J Immunol 1998;161:3357–64.
   PubMed Web of Science ®Google Scholar
• Brocke S, Gijbels K, Allegretta M, Ferber I, Piercy C, Blankenstein T, et al. Treatment of experimental encephalomyeli-tis with a peptide analogue of myelin basic protein. Nature 1996;379:343–6.
   PubMed Web of Science ®Google Scholar
• Windhagen A, Scholz C, Hollsberg P, Fukaura H, Sette A, Haller DA. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 1995;2:373–80.
   PubMed Web of Science ®Google Scholar
• Ausubel LJ, Krieger JI, Haller DA. Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85–99. J Immunol 1997;159: 2502–12.
   Google Scholar
• Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med 2000;6: 1167–75.
   PubMed Web of Science ®Google Scholar
• Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P, et al. Induction of a non-encephalitogenic type 2 T helper-cell autoim-mune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat Med 2000;6:1176–82.
   Google Scholar
• Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002;3:940–3.
   PubMed Web of Science ®Google Scholar
• Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, Teyton L, et al. Structural basis of plasticity in T cell receptor recognition of a self-peptide—MHC antigen. Science 1998;279:1166–72.
   PubMed Web of Science ®Google Scholar